Cargando…

Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients

Insulin-like growth factor 1 receptor (IGF1R) is a receptor tyrosine kinase that regulates cell growth and proliferation. Upregulation of the IGF1R pathway constitutes a common paradigm shared with other receptor tyrosine kinases such as EGFR, HER2, and MET in different cancer types, including colon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveres, Helena, Pesántez, David, Maurel, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126031/ https://www.ncbi.nlm.nih.gov/pubmed/34065119 http://dx.doi.org/10.3390/ijms22095019

Ejemplares similares

Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53–Mutated Metastatic Colorectal Cancer
por: Lahoz, Sara, et al.
Publicado: (2022)

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
por: Rodriguez, Adela, et al.
Publicado: (2021)

New developments in targeted therapy for metastatic colorectal cancer
por: Wong, Ambrose H. N., et al.
Publicado: (2023)

The Tumor Microenvironment in Colorectal Cancer Therapy
por: Pedrosa, Leire, et al.
Publicado: (2019)

Role of targeted therapy in metastatic colorectal cancer
por: Ohhara, Yoshihito, et al.
Publicado: (2016)

Current Targeted Therapy for Metastatic Colorectal Cancer
por: Ohishi, Tomokazu, et al.
Publicado: (2023)

Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
por: Tang, Yuan-Ling, et al.
Publicado: (2023)

Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
por: Sun, Weijing
Publicado: (2012)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies
por: Galbraith, Norman J., et al.
Publicado: (2021)

Primary metastatic prostate cancer between prognosis or adequate/proper medical therapy
por: Mustafa, Mahmoud, et al.
Publicado: (2021)

Metastatic colorectal cancer-prolonging overall survival with targeted therapies
por: Dattatreya, Satya
Publicado: (2013)

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
por: Lee, Suk-young, et al.
Publicado: (2016)

A Review of Translational Research for Targeted Therapy for Metastatic Colorectal Cancer
por: Ruff, Samantha M., et al.
Publicado: (2023)

Prostate cancer between prognosis and adequate/proper therapy
por: Grozescu, T, et al.
Publicado: (2017)

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
por: Aparicio, Jorge, et al.
Publicado: (2022)

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
por: Codony-Servat, Jordi, et al.
Publicado: (2017)

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009)

Molecularly targeted drugs for metastatic colorectal cancer
por: Cheng, Ying-dong, et al.
Publicado: (2013)

Molecular Targets for the Treatment of Metastatic Colorectal Cancer
por: Cohen, Romain, et al.
Publicado: (2020)

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
por: Español-Rego, Marta, et al.
Publicado: (2022)

Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAF(V600E)-Specific Inhibitor)
por: Torres-Collado, Antoni Xavier, et al.
Publicado: (2018)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mulcahy, Mary F
Publicado: (2008)

Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer
por: Dazio, Giulia, et al.
Publicado: (2022)

Recent developments in the treatment of metastatic colorectal cancer
por: Loree, Jonathan M., et al.
Publicado: (2017)

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned
por: Thomas, Christian, et al.
Publicado: (2016)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
por: Dmello, Rhynelle S., et al.
Publicado: (2021)

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer
por: Kano, Yoshihito, et al.
Publicado: (2023)

Optimizing the use of anti VEGF targeted therapies in patients with metastatic colorectal cancer: review of literature
por: HOPIRTEAN, CLAUDIU, et al.
Publicado: (2018)

SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
por: Fernández Montes, Ana, et al.
Publicado: (2023)

Recent developments and translational aspects in targeted therapy for metastatic breast cancer
por: Marhold, Maximilian, et al.
Publicado: (2016)

Impact of the COVID-19 Pandemic on the Elective Surgery for Colorectal Cancer: Lessons to Be Learned
por: Feier, Catalin Vladut Ionut, et al.
Publicado: (2022)

Targeting metastatic colorectal cancer – present and emerging treatment options
por: Ciombor, Kristen K, et al.
Publicado: (2014)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2009)

Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
por: Wang, Nannan, et al.
Publicado: (2022)

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
por: Zisi, Asimina, et al.
Publicado: (2022)

Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer
por: Fuloria, Jyotsna
Publicado: (2012)

Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
por: Aparicio, Jorge, et al.
Publicado: (2020)

The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
por: Antoniotti, Carlotta, et al.
Publicado: (2018)

Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
por: Baek, Sun Kyung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r8puinar2um847knovn3hi8o0e